Patriot Battery Metals Inc. (ASX:PMT) Launches 2025 Winter Drill Program
Patriot Battery Metals Inc. (ASX:PMT) launches its 2025 winter drill program at Shaakichiuwaanaan Property, targeting 15,000m over four months.
Tag: Corporate Strategy & Guidance
Dexus Convenience Retail REIT (ASX:DXC) Reports Half-Year Results
Dexus Convenience Retail REIT (ASX:DXC) declares a 10.3c distribution and reports strong financial and portfolio performance in the half-year results.
VIP Gloves Limited (ASX:VIP) Secures RM2.75 Million Short Term Loan Ahead of Share Placement
VIP Gloves Limited (ASX:VIP) secures RM2.75 million short-term loan ahead of its share placement and potential ASX delisting.
Smartgroup Corporation Ltd (ASX:SIQ) Secures Monash Health Contract for Salary Packaging
Smartgroup Corporation Ltd (ASX:SIQ) secures a contract with Monash Health to provide salary packaging and novated leasing services for 25,000 employees.
Nagambie Resources (ASX:NAG) Announces Research Findings on Whroo Project
Nagambie Resources (ASX:NAG) reports significant research findings on its Whroo Project, highlighting high-grade antimony and gold assays.
Albion Resources Limited (ASX:ALB) Identifies New Priority Gold Targets
Albion Resources (ASX:ALB) identifies significant new gold targets at Yandal West, highlighting exploration potential and upcoming drilling plans.
Terramin Australia Ltd (ASX:TZN) Updates on Bird in Hand Gold Project Appeal
Terramin Australia (ASX:TZN) updates on the legal appeal and operational progress of its Bird in Hand Gold Project, highlighting significant economic benefits for South Australia.
Red Metal Limited (ASX:RDM) Confirms Sybella Rare Earth Discovery Continuity
Red Metal Limited (ASX:RDM) confirms the strong continuity of its Sybella rare earth discovery through infill drilling, enhancing resource confidence.
Trek Metals Limited (ASX:TKM) Announces High-Grade Manganese Discovery
Trek Metals Limited (ASX:TKM) announces high-grade manganese discoveries at Pearana Prospect, highlighting strong exploration results and future drill plans.
PYC Therapeutics (ASX:PYC) Receives Approval to Begin Human Trials for PKD Treatment
PYC Therapeutics (ASX:PYC) receives regulatory approval to commence human trials for its PKD drug candidate, PYC-003.